Produktname:(+/-)-Narwedine

IUPAC Name:(1S,12S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-one

CAS:1668-86-6
Molekulare Formel:C17H19NO3
Reinheit:95%
Katalognummer:CM244272
Molekulargewicht:285.34

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM244272-250mg in stock ľľ
CM244272-1g in stock Ůƚƈ
CM244272-5g in stock ľŌŮ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1668-86-6
Molekulare Formel:C17H19NO3
Schmelzpunkt:-
SMILES-Code:O=C1C=C[C@@]23CCN(C)CC4=CC=C(OC)C(O[C@@]3([H])C1)=C24
Dichte:
Katalognummer:CM244272
Molekulargewicht:285.34
Siedepunkt:
Mdl-Nr.:MFCD13193038
Lagerung:

Column Infos

ZUNVEYL
Alpha Cognition announced that the FDA has granted approval for ZUNVEYL® (benzgalantamine) previously known as ALPHA-1062, for the treatment of mild-to-moderate Alzheimer’s disease. ZUNVEYL, a prodrug of AD treatment galantamine and an acetylcholinesterase inhibitor (AChEI), is postulated to exert its therapeutic effect by preventing the breakdown of acetylcholine, the important brain neurotransmitter involved in memory, motivation, and attention functions. The approval of ZUNVEYL is a pivotal moment in the fight against Alzheimer’s disease as it is only the second oral AD treatment to be approved in more than a decade.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products